Back HIV Populations

HIV Populations

IAS 2015: HIV Treatment Scale-up Linked to Reduced Mortality Among Vancouver Drug Injectors

HIV-related and all-cause death decreased significantly among people who inject drugs -- with similar declines for both women and men -- since the introduction of expanded access to antiretroviral therapy (ART) as part of a "treatment as prevention" initiative in Vancouver, researchers reported last month at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention. These findings support recommendations to treat everyone with HIV, both to benefit their own health and to reduce transmission.

alt

Read more:

Updated Guidelines for Pregnant Women with HIV and Preventing Mother-to-Child Transmission

The U.S. Department of Health and Human Services last week released an update to its Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Notable changes include discussion of antiretroviral treatment as prevention and pre-exposure prophylaxis (PrEP) for serodiscordant couples wishing to conceive, and a new section on options for perinatally infected women who are now pregnant themselves.

alt

Read more:

IAS 2015: Intensification of ART Reduces Risk of Late-term Mother-to-Child HIV Transmission

Maternal and infant antiretroviral therapy (ART) intensification is very effective in preventing HIV transmission during labor and birth from pregnant women with HIV in Thailand who present late for care, with less than 8 weeks of standard ART, Marc Lallemant reported at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) last month in Vancouver.

alt

Read more:

IAS 2015: Implant and Injectable Hormonal Contraception Most Effective Methods for Women with HIV

Hormonal contraceptive methods are highly effective in reducing the risk of pregnancy in women living with HIV whether on antiretroviral therapy (ART) or not, according to an evaluation involving over 5000 women, according to a report at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver last month.

alt

Read more:

IAS 2015: Raltegravir Prevents Mother-to-Child HIV Transmission During Late Pregnancy

Combination antiretroviral therapy containing the integrase inhibitor raltegravir (Isentress) appears safe and effective and may be an attractive option for treatment of pregnant women with HIV -- and potentially their infants -- to prevent perinatal transmission, according to study findings presented at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention last week in Vancouver.

alt

Read more: